Skip to main content
  • En
  • Français

Top Navigation

  • Newsroom
  • Contact Us

Main navigation

  • About Us
  • Products
  • Clinical Studies
  • Investors
  • News
  • En
  • Français
BioSenic

New SOLUTIONS

for inflammatory diseases and bone disorders

Our Team
Products
Investors
BioSenic

New SOLUTIONS

for inflammatory diseases and bone disorders

Our Team
Products
Investors
BioSenic

New SOLUTIONS

for inflammatory diseases and bone disorders

Our Team
Products
Investors

Our Executive Team

Products

BioSenic aims to become a leading company in the field of regenerative and immune medicine by developing innovative products for inflammatory diseases and bone disorders, as well as medical devices for these same areas.

Investors

All regulatory information and reports.

 

Clinical studies

Learn more about clinical development and our ongoing studies.

 

Publication des résultats annuels 2024

Communication des résultats annuels 2024

Our technology

BioSenic aims to become a leading company in the field of regenerative and immune medicine by developing innovative products for inflammatory diseases and bone disorders.

 

Stock information

BioSenic ( BIOS )

0.0024€

14.10.2025

Wallonie Eu Flag

BioSenic SA
Avenue Léon champagne, 3
1480 Saintes – Belgium
info@biosenic.com
 

Sign upfor our press releases

Receive information about BioSenic

Sign Up

Footer menu

  • Privacy Policy
  • Trademarks Copyrights
  • Users conditions